Furthermore, five of the ten genes (EIF5A2, SPP1, BNIP3, SRXN1 and LIMCH1) were upregulated in the recurrent tumours and could thus represent molecular drivers for aggressive cervical cancer disease. This evidence concerns the gene SRXN1 and cervical carcinoma.